Search Results - "BERNAREGGI, A"

Refine Results
  1. 1
  2. 2

    Clinical pharmacokinetics of nimesulide by BERNAREGGI, A

    Published in Clinical pharmacokinetics (01-10-1998)
    “…Nimesulide is a selective COX-2 inhibitor used in a variety of inflammatory, pain and fever states. After healthy volunteers received oral nimesulide 100 mg in…”
    Get full text
    Journal Article
  3. 3

    Adenosine enhances acetylcholine receptor channel openings and intracellular calcium 'spiking' in mouse skeletal myotubes by Bernareggi, A., Luin, E., Pavan, B., Parato, G., Sciancalepore, M., Urbani, R., Lorenzon, P.

    Published in Acta Physiologica (01-08-2015)
    “…Aims The autocrine activity of the embryonic isoform of the nicotinic acetylcholine receptor is crucial for the correct differentiation and trophism of…”
    Get full text
    Journal Article
  4. 4

    A phase I II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed refractory aggressive non-Hodgkin's lymphoma by Lim, Soon-Thye, Fayad, L., Tulpule, A., Modiano, M., Cabanillas, F., Laffranchi, B., Allievi, C., Bernareggi, A., Levine, Alexandra M.

    Published in Leukemia & lymphoma (01-02-2007)
    “…The purpose of the study was to evaluate the safety, efficacy, and pharmacokinetics of pixantrone (BBR2778) when substituted for etoposide in the ESHAP regimen…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex by Sessa, C., Capri, G., Gianni, L., Peccatori, F., Grasselli, G., Bauer, J., Zucchetti, M., Viganò, L., Gatti, A., Minoia, C., Liati, P., Van den Bosch, S., Bernareggi, A., Camboni, G., Marsoni, S.

    Published in Annals of oncology (01-08-2000)
    “…Objectives To define the maximum tolerated dose (MTD), the toxicity and pharmacokinetic profile of BBR3464, a novel triplatinum complex. Patients and methods…”
    Get full text
    Journal Article
  7. 7
  8. 8

    1784P - Gender effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of anamorelin (ANAM) in healthy volunteers and cancer patients with cachexia by Kaasa, S., Garcia, J.M., Bernareggi, A.

    Published in Annals of oncology (01-10-2019)
    “…ANAM, an oral selective ghrelin receptor agonist, showed benefits for patients with advanced non-small cell lung cancer (NSCLC) and anorexia/cachexia. A…”
    Get full text
    Journal Article
  9. 9
  10. 10

    1784PGender effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of anamorelin (ANAM) in healthy volunteers and cancer patients with cachexia by Kaasa, S, Garcia, J M, Bernareggi, A

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background ANAM, an oral selective ghrelin receptor agonist, showed benefits for patients with advanced non-small cell lung cancer (NSCLC) and…”
    Get full text
    Journal Article
  11. 11

    Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma by Borchmann, P., Schnell, R., Knippertz, R., Staak, J. O., Camboni, G. M., Bernareggi, A., Hübel, K., Staib, P., Schulz, A., Diehl, V., Engert, A.

    Published in Annals of oncology (01-05-2001)
    “…Background: BBR 2778 is a novel aza-anthracenedione showing no cardiotoxicity and superior activity compared to doxorubicin and mitoxantrone in animal models…”
    Get full text
    Journal Article
  12. 12

    Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy‐Induced Nausea and Vomiting by Gilmore, James, Bernareggi, Alberto

    Published in Journal of clinical pharmacology (01-04-2019)
    “…NEPA is the first fixed‐combination antiemetic composed of the neurokinin‐1 receptor antagonist netupitant (netupitant; 300 mg) and the 5‐hydroxytryptamine‐3…”
    Get full text
    Journal Article
  13. 13

    A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly by Dawson, L.K., Jodrell, D.I., Bowman, A., Rye, R., Byrne, B., Bernareggi, A., Camboni, G., Smyth, J.F.

    Published in European journal of cancer (1990) (01-12-2000)
    “…The anthracenedione analogue, BBR 2778 is an active antitumour agent preclinically and has reduced potential for cardiotoxicity compared with other similar…”
    Get full text
    Journal Article
  14. 14

    The pharmacokinetic profile of nimesulide in healthy volunteers by BERNAREGGI, A

    Published in Drugs (Basel) (1993)
    “…After oral administration of nimesulide 100mg in tablet, granule or suspension to healthy volunteers, the drug was rapidly and extensively absorbed. Mean peak…”
    Get full text
    Conference Proceeding Journal Article
  15. 15
  16. 16
  17. 17

    Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV) by Baron-Hay, Sally, Aapro, Matti, Bernareggi, Alberto, Schwartzberg, Lee

    Published in Supportive care in cancer (01-04-2019)
    “…Purpose The administration timing of antiemetic and chemotherapeutic regimens is often determined by regulatory indications, based on registration studies…”
    Get full text
    Journal Article
  18. 18

    Teicoplanin metabolism in humans by BERNAREGGI, A, BORGHI, A, BORGONOVI, M, CAVENAGHI, L, FERRARI, P, VEKEY, K, ZANOL, M, ZERILLI, L. F

    Published in Antimicrobial Agents and Chemotherapy (01-08-1992)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Binding of teicoplanin to human serum albumin by ASSANDRI, A, BERNAREGGI, A

    Published in European journal of clinical pharmacology (01-01-1987)
    “…The interaction between the main components of the new glycopeptide antibiotic teicoplanin, A2-2, A2-3, A2-4, A2-5 and A3-1, and human serum albumin has been…”
    Get full text
    Journal Article
  20. 20

    Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses by DEL FAVERO, A, PATOIA, L, ROSINA, R, BUNIVA, G, DANESE, A, BERNAREGGI, A, MOLINI, E, CAVENAGHI, L

    Published in Antimicrobial Agents and Chemotherapy (01-12-1991)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article